Contact hypersensitivity (CHS) induced by a
hapten is thought to be mediated by T helper type 1 (Th1) cells. However,
FITC can induce contact
allergy in vivo, and in vitro studies suggest that this response is Th2-type driven. We compared CHS reactions induced by
FITC or
dinitrofluorobenzene (
DNFB), a well-known Th1 inducing
hapten, in Balb/c mice, C57/B6 mice, and several gene knock-out mice, and investigated the role of Th1/Th2
cytokines, T cell populations, eosinophils, and mast cells. Balb/c mice (Th2 dominant strain) had a stronger response to
FITC than C57/B6 mice (Th1 dominant strain). The skin
inflammation was characterized by
edema and
eosinophilia, and serum
IgE levels were elevated following
FITC challenge. All responses were enhanced by a second round of sensitization. Anti-
TNF-alpha or anti-
very late antigen-4 (VLA-4) antibody partly inhibited both
FITC- and
DNFB-induced CHS. Pretreatment of mice with anti-IL-4 antibody, anti-IL-5 antibody, recombinant INF-gamma, or the mast-cell depleting
agent 48/80 significantly diminished
edema formation, and Stat6(-/-) mice were fully protected from
FITC-induced CHS, while
DNFB-induced CHS was enhanced (Stat6(-/-), mast cell depletion) or not affected (anti-IL-5 antibody). Further, mice lacking CD4(+) T cells and mice lacking both CD8 and MHC II showed very little reaction at all to
FITC, while the absence of CD8 T cells alone or MHC II alone conferred partial protection only. These findings indicate a contribution of MHC II-independent CD4(+) T cells and/or CD4(+) NKT cells to the Th2 response triggered by
FITC in vivo, and makes
FITC-induced CHS a suitable animal model for
atopic dermatitis.